Part,  Chapter, Paragraph

 1    I,     2. 10.  4|           spent in the dispensary by 34% for pharmacists and 51%
 2   II,     4.  3    |           Health and Human Services: 34.~ ~Van Oyen, H., J. van
 3   II,     5.  2.  3|          age-range, CVD accounts for 34% of total mortality and
 4   II,     5.  2.  3|             225 to 142 per 100.000), 34% in Southern Europe countries6 (
 5   II,     5.  2.  3|              110 to 87 per 100.000), 34% in Central Eastern Europe (
 6   II,     5.  2.  7|             Arch Intern Med 165:1028-34.~EUROCISS Project Research
 7   II,     5.  2.  7|            or case fatality?. Stroke 34:1833-1841~Thom TJ (1989):
 8   II,     5.  3.  2|            2005, collected data from 34 European countries regarding
 9   II,     5.  3.  5|            17 deaths (in Iceland) to 34 deaths per 100,000 (in Denmark).
10   II,     5.  3.  6|             Sweden (70%) (Figure 5.3.34) (Sant et al, 2003). Survival
11   II,     5.  3.  6|              al, 2003).~ ~Figure 5.3.34. Cervical cancer (ICD9 180)
12   II,     5.  5.  3|              show a peak in the 3034 age group and again between
13   II,     5.  5.  3|            in Italy, 35% in Denmark, 34% in Hungary, 26% in Germany,
14   II,     5.  5.  3|           Wirksamkeit. Psychiat Prax 34(1):S28-S32.~Priebe S (2007):
15   II,     5.  5.  3|       studies on epilepsy. Epilepsia 34:592-596.~Employment Committee
16   II,     5.  6.  6|           Norway. Scand J Soc Med 26:34-43~Brooks PM (1997): MJA
17   II,     5.  6.  6|        ESCISIT). Ann Rheum Dis 66(1):34-45~Cooper C (1997): The
18   II,     5.  6.  6|     Chingford Study. Arthritis Rheum 34, S171~ ~Spector TD, Hart
19   II,     5.  8.  3| complications and exacerbations, and 34% to other diseases, one-third
20   II,     5.  8.  7|           disease. Intern Med J 2004;34(11):608-14~ ~ ~Schirnhofer
21   II,     5.  9.  4| significantly narrowed for wheeze (1.34 to 0.98:1 P <0.0002), asthma (
22   II,     5. 10.  7|             L 75, 22.03.2005, pp. 3334.~htt ~ ~European Commission (
23   II,     5. 11.  3|             Environment, 2007;388:24-34.~L Dotterud, E Falk, Metal
24   II,     5. 11.  3|       following age groups:1524, 2534, 3554 and 5574, respectively (
25   II,     5. 11.  7|             J Dermatol 1994;131(S44):34.~ ~Johnson M-LT (1978):
26   II,     5. 12.  3|               as well as in Austria (34.5) and Hungary (33.9), while
27   II,     5. 12.  3|         whose rates declined from 27-34 in 1980-82 to 18-20/100,
28   II,     5. 12.  7|          randomized trial. Endoscopy 34:690-697.~ ~Schuppan D, Afdhal
29   II,     6.  3.  3|            were reported by Ireland (34.99), Sweden (28.96), and
30   II,     6.  3.  6|              000 per year). In 2005, 34 cases were reported by 20
31   II,     7.  3.  1|            000 Hospital Admissions~- 34 200 000 Hospital Outpatients~-
32   II,     7.  3.  2|          injury fatalities are male, 34% female (Figure 7.3).~ ~
33   II,     8.  2.  1|              mental retardation of 0.34% (Bersen, 1976).~ ~Prevalence
34   II,     9        |           Smoking Among all Women 25-34 vs Women During 3rd Trimester
35   II,     9.  1.  2|           Smoking Among all Women 25-34 vs Women During 3rd Trimester
36   II,     9.  3.  1|           000 population), to the 25-34 age group (11.2 per 100
37   II,     9.  3.  1|              of death in men aged 15-34 as deaths due to pulmonary
38   II,     9.  3.  1|          rise between the ages of 25-34 and 35-44 in the rate of
39   II,     9.  3.  1|             40-49, 15.7% aged 50-59, 34.4% aged 60-69 and 53.4%
40   II,     9.  3.  2|           outcomes after birth at 30-34 weeks of gestation. Obstet
41   II,     9.  3.  3|           1989-2003). Arch Sex Behav 34:219-29.~Hessling A (Ed.) (
42  III,    10.  2.  1|           one occasion and a further 34% 5 or more drinks (50g alcohol).
43  III,    10.  2.  1|              use in young adults (15-34 y) have been registered
44  III,    10.  2.  1|           use among young adults (15-34 year old)~ ~Most drug use
45  III,    10.  2.  1|             is taking place among 15-34 year olds and lifetime prevalence
46  III,    10.  2.  1|             young adults (aged 15 to 34)~ ~Drug use in the European
47  III,    10.  2.  1|             64) and young adults (15-34). Nowadays, we can observe
48  III,    10.  2.  1|             cocaine use among the 1534 age group have been registered
49  III,    10.  2.  1|          Starting with Eurobarometer 34 (1990) separate supplementary
50  III,    10.  2.  1|            found that about a third (34%) reported enough physical activity
51  III,    10.  2.  1|         survey indicating that up to 34% of 13-year-old boys versus
52  III,    10.  2.  1|          showed a range of 7-27% and 34-68%, respectively. The few
53  III,    10.  2.  1|            Commission Directive 2006/34/EC (European Commission,
54  III,    10.  2.  1|    Commission (2006): Directive 2006/34/EC of 21 March 2006 amending
55  III,    10.  4.  2|       Chapter V (articles 26 through 34) considers the following
56  III,    10.  4.  2|            regard to Article 23f and 34 of Regulation (EC) 178/2002,
57  III,    10.  4.  2|            2006): Directive No. 2006/34/EC of 21 March 2006 amending
58  III,    10.  4.  3|            60%) of the outbreaks and 34.8% of the cases of illnesses.
59  III,    10.  4.  5|              from 27% in 1990 to 33%-34% in 2005, with exports being
60  III,    10.  5.  2|              Poland, Slovakia~Rural: 34~Urban: 17~ ~2006-Accession
61  III,    10.  6.  2|           countries. Int J Epidemiol 34: 316-326.~ ~EUROTHINE (2007):
62   IV,    11.  2.  1|           beds can be seen in Malta (34%), the Netherlands (33%),
63   IV,    12.  5    |              parliamentary decision (34/2001/EC, adopted by the
64   IV,    12. 10    |              Directives 93/104, 2000/34’’~o Presidential Degrees